Citations

Showing 10 of 108162 citations.

What Is the Role of Sphingosine-1-Phosphate Receptors in Pain?
Benarroch, Eduardo E.

Mayo Clinic

Neurology | March 15, 2021 | Volume: 96 | Issue: 11 | Pages: 525-528

10.1212/wnl.0000000000011605 | PMID 33723022 Get It

In Response
Prielipp, Richard C., Brull, Sorin J. , Brull, Sorin J , Fülesdi, Béla

Mayo Clinic

Anesthesia & Analgesia | March 15, 2021 | Volume: 132 | Issue: 4 | Pages: e61-e63

10.1213/ane.0000000000005414 | PMID 33723200 Get It

Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival
Wenzel, Lari , Osann, Kathryn , McKinney, Chelsea , Cella, David , Fulci, Giulia , Scroggins, Mary Jackson, Lankes, Heather A. , Wang, Victoria , Nephew, Kenneth P. , Maxwell, G. Larry , Mok, Samuel C. , Miller, Austin , Mannel, Robert S., Gray, Heidi J. , Hanjani, Parviz, Huh, Warner K. , Spirtos, Nick M. , Sharma, Sudarshan , Santin, Alessandro D. , Sperduto, Paul W. , Lele, Shashikant B., Burger, Robert A. , Monk, Bradley J. , Birrer, Michael J. , Miller, Austin , Spirtos, Nick , Glaser, Gretchen , Monk, Bradley J , Mok, Samuel C , Conrads, Thomas , Leitão, Mario M. , Glaser, Gretchen

Mayo Clinic

JNCI: Journal of the National Cancer Institute | March 15, 2021 | Volume: 113 | Issue: 10 | Pages: 1369-1378

10.1093/jnci/djab034 | PMID 33729494 Get It

Abstract Background There is a critical need to identify patient characteristics associated with long-term ovarian cancer survival. Methods Quality of life (QOL), measured by the Functional Assessment of Cancer Therapy-Ovarian-Trial Outcome Index (FACT-O-TOI), including physical, functional, and ovarian-specific subscales, was compared between long-term survivors (LTS) (8+ years) and short-term survivors (STS) (<5 years) of GOG 218 at baseline; before cycles 4, 7, 13, 21; and 6 months post-treatment using linear and longitudinal mixed models adjusted for covariates. Adverse events (AEs) were compared between survivor groups at each assessment using generalized linear models. All P values are 2-sided. Results QOL differed statistically significantly between STS (N = 1115) and LTS (N = 260) (P < .001). Baseline FACT-O-TOI and FACT-O-TOI change were independently associated with long-term survival (odds ratio = 1.05, 95% confidence interval = 1.03 to 1.06 and odds ratio = 1.06, 95% confidence interval = 1.05 to 1.07, respectively). A 7-point increase in baseline QOL was associated with a 38.0% increase in probability of LTS, and a 9-point increase in QOL change was associated with a 67.0% increase in odds for LTS. QOL decreased statistically significantly with increasing AE quartiles (cycle 4 quartiles: 0-5 vs 6-8 vs 9-11 vs ≥12 AEs, P = .01; cycle 21 quartiles: 0-2 vs 3 vs 4-5 vs ≥6 AEs, P = .001). Further, LTS reported statistically significantly better QOL compared with STS (P = .03 and P = .01, cycles 4 and 21, respectively), with similar findings across higher AE grades. Conclusions Baseline and longitudinal QOL change scores distinguished LTS vs STS and are robust prognosticators for long-term survival. Results have trial design and supportive care implications, providing meaningful prognostic value in this understudied population.
Presentation and outcomes of adrenal ganglioneuromas: A cohort study and a systematic review of literature
Dages, Kelley N. , Kohlenberg, Jacob , Rivera, Michael , Dy, Benzon M. , Foster, Trenton R. , Lyden, Melanie L. , McKenzie, Travis J. , Thompson, Geoffrey B. , Kohlenberg, Jacob D, Murad, Mohammad Hassan, Foster, Trenton, Lyden, Melanie, Young, William F. , Murad, M. Hassan , Prokop, Larry J. , Bancos, Irina

Mayo Clinic

Clinical Endocrinology | March 15, 2021 | Volume: 95 | Issue: 1 | Pages: 47-57

10.1111/cen.14460 | PMID 33721367 Get It

AbstractObjectiveTo describe the presentation and outcomes of patients with adrenal ganglioneuromas (AGNs).DesignSingle‐centre retrospective cohort study (1 January 1995 to 31 December 2019) and systematic review of literature (1 January 1980 to 19 November 2019).PatientsDiagnosed with histologically confirmed AGN.MeasurementsBaseline clinical, imaging and biochemical characteristics, recurrence rates and mortality. Subgroup analysis was performed on tumours with histologic elements of ganglioneuroma and pheochromocytoma (ie composite tumours).ResultsThe cohort study included 45 patients with AGN, 20 (44%) of which had composite tumours. Compared to pure AGN, patients with composite tumour were older (median age, 62.5 vs. 35 years, p < .001), had smaller tumours (median size, 3.9 vs. 5.7 cm, p = .016) and were discovered incidentally less frequently (65% vs. 84%, p = .009). No recurrences or ganglioneuroma‐specific mortality occurred during follow‐up (range, 0–266 months). The systematic review included 14 additional studies and 421 patients. The mean age of diagnosis was 39 years, and 47% were women. AGNs were discovered incidentally in 72% of patients, were predominantly unilateral (99%) and had a mean diameter of 5.8 cm and an unenhanced computed tomography (CT) attenuation of −118 to 49 Hounsfield units (HU). On imaging, 69% of AGNs were homogenous, 41% demonstrated calcifications, and 40% were lobulated.ConclusionsAGNs are rare benign tumours that present with variable imaging features including large size, unenhanced CT attenuation >20 HU, calcifications and lobulated shape. Imaging characteristics can assist in establishing a diagnosis and avoiding an unnecessary adrenalectomy. The association of pheochromocytomas with AGNs is frequent. Diagnosis should include biochemical testing.
BRAF V600E Mutation in First-Line Metastatic Colorectal Cancer: An Analysis of Individual Patient Data From the ARCAD Database
Cohen, Romain , Liu, Heshan , Fiskum, Jack, Adams, Richard , Chibaudel, Benoist , Maughan, Tim , Venook, Alan P. , Douillard, Jean‐Yves , Heinemann, Volker , Punt, Cornelis J.A. , Bokemeyer, Carsten , Lenz, Heinz‐Josef , Koopman, Miriam , Zalcberg, John , Grothey, A., Gramont, Aimery de , Shi, Qian , Maughan, Timothy S , Venook, Alan P , Heinemann, Volker , Falcone, Alfredo , Bokemeyer, Carsten , Kaplan, Richard , Lenz, Heinz-Josef , Koopman, Miriam , Shi, Qian , Zalcberg, John , Adams, Richard , Chibaudel, Benoist , Cohen, Romain , Cutsem, Eric Van , Falcone, Alfredo , Kaplan, Richard , Yoshino, Takayuki , André, Thierry

Mayo Clinic

JNCI: Journal of the National Cancer Institute | March 15, 2021 | Volume: 113 | Issue: 10 | Pages: 1386-1395

10.1093/jnci/djab042 | PMID 33734401 Get It

Abstract Background First-line therapeutic strategies for patients with BRAFV600E-mutated (BRAFmt) metastatic colorectal cancer (mCRC) mainly rely on subgroup analyses from randomized controlled trials (RCTs). We aimed to assess the prognostic and predictive impact of BRAFmt on the efficacy of targeted therapies with first-line chemotherapy. Methods Individual patient data from first-line RCTs with BRAF and KRAS status data in the ARCAD database were pooled. Progression-free survival and overall survival (OS) were assessed using Kaplan-Meier and Cox models. Outcomes were compared between treatment groups that were concurrently randomly assigned whenever possible. Results A total of 6391 patients from 10 RCTs were included: 573 BRAFmt (9.0%), 2059 KRASmt (32.2%), and 3759 double wild type (58.8%). BRAFmt mCRC patients experienced statistically significantly poorer OS than those with KRASmt (adjusted hazard ratio [HRadj] = 1.46, 95% confidence interval [CI] = 1.30 to 1.64) and patients with double wild-type tumors (HRadj = 2.14, 95% CI = 1.94 to 2.36). Anti-EGFR agents did not improve progression-free survival or OS of BRAFmt mCRC patients, based on 4 RCTs testing chemotherapy with or without anti-epidermal growth factor receptor (anti-EGFR) (HRadj = 0.96, 95% CI = 0.71 to 1.30; and HRadj = 0.85, 95% CI = 0.66 to 1.14, respectively). Conclusions Our data suggest that the addition of anti-EGFR agents to chemotherapy is ineffective as first-line treatment for BRAFmt mCRC patients.
Bone Aging, Cellular Senescence, and Osteoporosis
Pignolo, Robert J. , Law, Susan F., Chandra, Abhishek , Chandra, Abhishek

Mayo Clinic

JBMR Plus | March 15, 2021 | Volume: 5 | Issue: 4 | Pages: No page available

10.1002/jbm4.10488 | PMID 33869998 Get It

ABSTRACT Changes in aging bone that lead to osteoporosis are mediated at multiple levels, including hormonal alterations, skeletal unloading, and accumulation of senescent cells. This pathological interplay is superimposed upon medical conditions, potentially bone‐wasting medications, modifiable and unmodifiable personal risk factors, and genetic predisposition that accelerate bone loss with aging. In this study, the focus is on bone hemostasis and its dysregulation with aging. The major physiological changes with aging in bone and the role of cellular senescence in contributing to age‐related osteoporosis are summarized. The aspects of bone aging are reviewed including remodeling deficits, uncoupling phenomena, inducers of cellular senescence related to bone aging, roles of the senescence‐associated secretory phenotype, radiation‐induced bone loss as a model for bone aging, and the accumulation of senescent cells in the bone microenvironment as a predominant mechanism for age‐related osteoporosis. The study also addresses the rationale and potential for therapeutic interventions based on the clearance of senescent cells or suppression of the senescence‐associated secretory phenotype. © 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
Analysis and Classification of Postcatheterization Femoral Arteriovenous Fistulas Based on Color Doppler Examinations
Middleton, William D. , Robinson, Kathryn A.

Mayo Clinic

Journal of Ultrasound in Medicine | March 15, 2021 | Volume: 41 | Issue: 1 | Pages: 207-216

10.1002/jum.15696 | PMID 33720458 Get It

ObjectiveTo analyze and classify arterial supply and venous drainage of postcatheterization femoral arteriovenous fistulas (AVFs).MethodsA review of extremity Doppler reports identified 77 femoral AVFs in 75 patients. Doppler exams were reviewed retrospectively. Fistulas were classified as above or below the common femoral artery bifurcation and subclassified based on the location of arterial inflow and venous outflow.ResultsArterial inflow originated above the femoral bifurcation in 32 cases. The communication was between the common femoral artery and the superficial circumflex iliac vein in 25 of 32 cases and between a branch of the common femoral or external iliac artery and the common femoral or external iliac vein in 4 of 32 cases. In 3 of 32 cases, AVFs arose from the common femoral artery, but the venous outflow was not determined. Arterial inflow originated from the superficial femoral artery in 23 cases. Venous outflow originated from the common femoral vein in 10 of 23 cases, the femoral vein in 7 of 23 cases, and the lateral circumflex femoral vein in 6 of 23 cases. Arterial inflow originated from the deep femoral artery in 12 cases. Venous outflow originated from the common femoral vein in 6 of 12 cases and from the lateral circumflex femoral vein 6 of 12 cases. In 8 cases, the AVF originated below the bifurcation, but the arterial inflow was not classified. In 2 cases, it was impossible to determine if the AVF originated above or below the bifurcation.ConclusionsIatrogenic femoral AVFs arise above the femoral bifurcation more often than previously recognized. Classification based on the arterial inflow and venous outflow provides a straightforward means of describing these fistulas.
Preclinical testing platforms for mechanical thrombectomy in stroke: a review on phantoms, in-vivo animal, and cadaveric models
Liu, Yang , Abbasi, Mehdi , Larco, Jorge Arturo , Kadirvel, Ramanathan , Kallmes, David F. , Brinjikji, Waleed , Arturo Larco, Jorge L, Savastano, Luis , Arturo Larco, Jorge L , Liu, Yang

Mayo Clinic

Journal of NeuroInterventional Surgery | March 15, 2021 | Volume: 13 | Issue: 9 | Pages: 816-822

10.1136/neurintsurg-2020-017133 | PMID 33722966 Get It

Preclinical testing platforms have been instrumental in the research and development of thrombectomy devices. However, there is no single model which fully captures the complexity of cerebrovascular anatomy, physiology, and the dynamic artery-clot-device interaction. This article provides a critical review of phantoms, in-vivo animal, and human cadaveric models used for thrombectomy testing and provides insights into the strengths and limitations of each platform. Articles published in the past 10 years that reported thrombectomy testing platforms were identified. Characteristics of each test platform, such as intracranial anatomy, artery tortuosity, vessel friction, flow conditions, device-vessel interaction, and visualization, were captured and benchmarked against human cerebral vessels involved in large-vessel occlusion stroke. Thrombectomy phantoms have been constructed from silicone, direct 3D-printed polymers, and glass. These phantoms represent oversimplified patient-specific cerebrovascular geometry but enable adequate visualization of devices and clots under appropriate flow conditions. They do not realistically mimic the artery-clot interaction. For the animal models, arteries from swine, canines, and rabbits have been reported. These models can reasonably replicate the artery-clot-device interaction and have the unique value of evaluating the safety of thrombectomy devices. However, the vasculature geometries are substantially less complex and flow conditions are different from human cerebral arteries. Cadaveric models are the most accurate vascular representations but with limited access and challenges in reproducibility of testing conditions. Multiple test platforms should be likely used for comprehensive evaluation of thrombectomy devices. Interpretation of the testing results should take into consideration platform-specific limitations.
Television‐induced electronegative photoparoxysmal response: an extratemporal seizure mimic?
Calado, Gabriel, Desai, Nimit , Kasteleijn, Dorothee, Tatum, William O.

Mayo Clinic

Epileptic Disorders | March 15, 2021 | Volume: 23 | Issue: 1 | Pages: 161-166

10.1684/epd.2021.1239 | PMID 33602663 Get It

AbstractVideo‐EEG monitoring is an established gold‐standard procedure for diagnosis and differentiation of epileptic and non‐epileptic seizures. Epilepsy misdiagnosis, to which factors such as EEG artifact misinterpretation contribute to, is common, and can have long‐lasting iatrogenic repercussions to the clinical management of affected patients. Among the many types of responses to photic stimulation, artifacts and physiologic and epileptic responses are possible. All of these can interfere with EEG interpretation when provoked by a source of illumination. Photic‐induced responses are of increasing relevance given the ubiquity of screens and other light‐emitting electronics in our modern world. One of these, the photoparoxysmal response, is a frequent finding in photosensitive patients with genetic generalized epilepsies. Various responses beyond abnormal occurrence of cortical spikes or spike‐and‐wave discharges are known to occur on EEG in response to intermittent photic stimulation (IPS), with different clinical implications. To our knowledge, we report a unique electronegative photoparoxysmal response during video‐EEG monitoring induced by fluctuating illumination caused by a distant television screen. This response mimicked an extratemporal seizure in a young woman with frontal lobe epilepsy, admitted for presurgical evaluation. Novel electronegative responses to electronic devices during video‐EEG monitoring merit consideration by EEG interpreters to help avoid misdiagnosis.